Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding
Published on: June 2, 2026, 10:15 a.m. | Source: The Economic Times
Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak in Africa. The vaccine uses technology similar to the Oxford-AstraZeneca Covid-19 vaccine. This partnership aims to accelerate development and ensure access for affected nations.
